Genetic association of preeclampsia to the inflammatory response gene SEPS1

Roberts, 2005, Preeclampsia: recent insights, Hypertension, 46, 1243, 10.1161/01.HYP.0000188408.49896.c5 Pijnenborg, 2006, The uterine spiral arteries in human pregnancy: facts and controversies, Placenta, 27, 939, 10.1016/j.placenta.2005.12.006 Levine, 2006, Soluble endoglin and other circulating antiangiogenic factors in preeclampsia, N Engl J Med, 355, 992, 10.1056/NEJMoa055352 Rodie, 2004, Pre-eclampsia and cardiovascular disease: metabolic syndrome of pregnancy?, Atherosclerosis, 175, 189, 10.1016/j.atherosclerosis.2004.01.038 Libby, 2002, Inflammation in atherosclerosis, Nature, 420, 868, 10.1038/nature01323 Jauniaux, 2006, Placental-related diseases of pregnancy: involvement of oxidative stress and implications in human evolution, Hum Reprod Update, 12, 747, 10.1093/humupd/dml016 Sargent, 2006, NK cells and human pregnancy—an inflammatory view, Trends Immunol, 27, 399, 10.1016/j.it.2006.06.009 Redman, 1999, Preeclampsia: an excessive maternal inflammatory response to pregnancy, Am J Obstet Gynecol, 180, 499, 10.1016/S0002-9378(99)70239-5 Chen, 1996, Tumour necrosis factor-alpha (TNF-alpha) gene polymorphism and expression in pre-eclampsia, Clin Exp Immunol, 104, 154, 10.1046/j.1365-2249.1996.d01-647.x Heiskanen, 2002, Polymorphism in the tumor necrosis factor-alpha gene in women with preeclampsia, J Assist Reprod Genet, 19, 220, 10.1023/A:1015306818507 Saarela, 2005, Tumour necrosis factor-alpha gene haplotype is associated with pre-eclampsia, Mol Hum Reprod, 11, 437, 10.1093/molehr/gah182 Kaiser, 2004, Association of the TNF2 allele with eclampsia, Gynecol Obstet Invest, 57, 204, 10.1159/000076689 Dizon-Townson, 1998, A promoter mutation in the tumor necrosis factor alpha gene is not associated with preeclampsia, J Reprod Immunol, 38, 55, 10.1016/S0165-0378(98)00008-4 Livingston, 2001, Lack of association of severe preeclampsia with maternal and fetal mutant alleles for tumor necrosis factor alpha and lymphotoxin alpha genes and plasma tumor necrosis factor alpha levels, Am Obstet Gynecol, 184, 1273, 10.1067/mob.2001.113124 Lachmeijer, 2001, Polymorphisms in the tumor necrosis factor and lymphotoxin-alpha gene region and preeclampsia, Obstet Gynecol, 98, 612 Freeman, 2004, Short- and long-term changes in plasma inflammatory markers associated with preeclampsia, Hypertension, 44, 708, 10.1161/01.HYP.0000143849.67254.ca Daher, 2006, Cytokine genotyping in preeclampsia, Am J Reprod Immunol, 55, 130, 10.1111/j.1600-0897.2005.00341.x Pfab, 2005, Impact of genes related to immune tolerance and inflammation (tumour necrosis factor-alpha, interleukin-6) on blood pressure, protein excretion and oedema in pregnancy, J Hypertens, 23, 2187, 10.1097/01.hjh.0000188732.52722.5a Curran, 2005, Genetic variation in selenoprotein S influences inflammatory response, Nat Genet, 37, 1234, 10.1038/ng1655 Holmen, 2003, The Nord-Trøndelag Health Study 1995-97 (HUNT2): objectives, contents, methods and participation, Nor J Epidemiol, 13, 19 Irgens, 2000, The medical Birth Registry of Norway Epidemiological research and surveillance throughout 30 years, Acta Obstet Gynecol Scand, 79, 435 Gifford, 2000, Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy, Am J Obstet Gynecol, 183, 1, 10.1067/mob.2000.107928 Braekke, 2005, Calprotectin, a marker of inflammation, is elevated in the maternal but not in the fetal circulation in preeclampsia, Am J Obstet Gynecol, 193, 227, 10.1016/j.ajog.2004.11.055 Schroder, 2005, The mammalian unfolded protein response, Annu Rev Biochem, 74, 739, 10.1146/annurev.biochem.73.011303.074134 Xu, 2005, Endoplasmic reticulum stress: cell life and death decisions, J Clin Invest, 115, 2656, 10.1172/JCI26373